Article
Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
British journal of pharmacology - 1 Jul 2001
Mabley J G, Suarez-Pinzon W L, Haskó G, Salzman A L, Rabinovitch A, Kun E, Szabó C
Abstract excerpt
Activation of poly(ADP-ribose) synthetase (PARS, also termed polyADP-ribose polymerase or PARP) has been proposed as a major mechanism contributing to beta-cell destruction in type I diabetes. In the present study, we have investigated the role of PARS in mediating the induction of diabetes and beta-cell death in the multiple-low-dose-streptozotocin (MLDS) model of type I diabetes. Mice genetically deficient in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.